Intercept Pharmaceuticals (ICPT) PT Lowered to $40 at RBC Capital

November 10, 2020 6:25 AM EST Send to a Friend

RBC Capital analyst Brian Abrahams ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Intercept Pharmaceuticals (ICPT) PT Lowered to $40 at RBC Capital

Member Login

Free News Feed